Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer [clinicaltrials:NCT00087347]
Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer [clinicaltrials:NCT00087347]
Bio2RDF identifier
NCT00087347
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00087347
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Diagnostic p ...... primary breast
cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Magnetic Resonance Imaging of ...... mary Prostate or Breast Cancer
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
Prim ...... ll be accrued for this study.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2004-07-08T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
recurrent breast cancer
recurrent prostate cancer
stage I breast cancer
stage I prostate cancer
stage II breast cancer
stage IIA prostate cancer
stage IIB prostate cancer
stage III prostate cancer
stage IIIA breast cancer
stage IIIB breast cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-05-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00087347
official title [clinicaltrials_vocabulary:official-title]
An NCI-Sponsored Exploratory S ...... l Lymph Node Biopsy/Dissection
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000374491
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2006-09-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
MGH-2004-P-000681/2
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-05-01T00:00:00Z
identifier
clinicaltrials:NCT00087347
title
Magnetic Resonance Imaging of ...... mary Prostate or Breast Cancer
@en
type
label
Magnetic Resonance Imaging of ...... r [clinicaltrials:NCT00087347]
@en